FADS1 rs174550: Understanding Your Fatty Acid Metabolism Variant
The rs174550 variant is a single-nucleotide polymorphism located in the FADS1 gene, which plays a critical role in how your body processes polyunsaturated fatty acids. Research indicates that this variant is associated with variations in blood fatty acid profiles, including levels of arachidonic acid and other lipid mediators.
What each genotype means
Higher fatty acid conversion
This genotype is associated with higher activity of the FADS1 enzyme, which helps convert dietary fats into long-chain polyunsaturated fatty acids like arachidonic acid. Research suggests that individuals with this genotype may show different responses to diets enriched with specific fatty acids, such as alpha-linolenic acid, regarding mitochondrial function and lipid profiles. This is a complex trait influenced by diet and ancestry, so please discuss any significant dietary changes or health concerns with a qualified healthcare provider.
The C allele has a reported frequency of approximately 0.30 in some genome-wide association studies, though the prevalence of the CC genotype varies significantly across different global populations.
Intermediate fatty acid conversion
Carrying one copy of each allele typically results in intermediate FADS1 enzyme activity compared to homozygous individuals. This genotype reflects a balanced genetic influence on how your body processes polyunsaturated fatty acids. Because this variant interacts with your dietary intake of fats, your specific metabolic response may depend on your overall nutritional patterns. Consult with a registered dietitian or physician if you are interested in how your genetics might relate to your lipid profile.
This heterozygous genotype is common in many populations, often representing a significant portion of the population depending on the specific ancestral background.
Lower fatty acid conversion
This genotype is associated with lower activity of the FADS1 enzyme, which can influence the body's ability to synthesize certain long-chain polyunsaturated fatty acids. Studies indicate that individuals with this genotype may have different requirements or metabolic responses when consuming diets high in linoleic or alpha-linolenic acids. As this variant is linked to broader metabolic traits, please consult with a healthcare professional to interpret these findings in the context of your overall health and diet.
The T allele is common globally, and the TT genotype is frequently observed in many populations, though exact frequencies vary by ancestry.
What is the rs174550 Variant?
The rs174550 variant is a specific change in the DNA sequence within the FADS1 gene, located on chromosome 11. In genetics, a single-nucleotide polymorphism (SNP) like rs174550 represents a position where one of the four chemical bases—adenine, thymine, cytosine, or guanine—differs between individuals. For rs174550, the two common alleles are cytosine (C) and thymine (T). This variant is frequently studied because it sits in a region of the genome that regulates the expression of enzymes responsible for converting dietary fats into more complex, long-chain polyunsaturated fatty acids (PUFAs). Because this SNP is often inherited alongside other nearby variants in the FADS gene cluster, it serves as a marker for broader genetic differences in how individuals synthesize and metabolize essential fats.
The Role of the FADS1 Gene
The FADS1 gene provides instructions for making an enzyme called delta-5 desaturase. This enzyme is a key player in the metabolic pathway that transforms shorter-chain fatty acids, such as linoleic acid and alpha-linolenic acid, into long-chain PUFAs like arachidonic acid (AA) and eicosapentaenoic acid (EPA). These long-chain fats are essential components of cell membranes and serve as precursors for signaling molecules called eicosanoids, which help regulate inflammation and other physiological processes. When the FADS1 gene functions efficiently, the body can effectively synthesize these necessary fats from dietary sources. Variations in the FADS1 gene, such as rs174550, can influence the activity level of the delta-5 desaturase enzyme, potentially leading to differences in the circulating levels of these important fatty acids in the blood.
Research Associations and Evidence
Scientific research has consistently linked the rs174550 variant to differences in blood fatty acid composition. Studies have observed that individuals carrying the ancestral C allele may exhibit different metabolic responses to dietary fat intake compared to those with the T allele. For instance, some research suggests that the genotype influences the conversion rate of dietary linoleic acid into arachidonic acid. While these associations are statistically significant in large population studies, the evidence is considered moderate because the actual impact on health outcomes can be complex and influenced by diet, lifestyle, and other genetic factors. Some studies have explored whether this variant modifies the risk of metabolic conditions or inflammatory responses, but results are often context-dependent. It is important to note that these findings are based on population-level data and do not predict individual health outcomes or disease risk.
What You Can Do With This Information
Understanding your FADS1 genotype provides insight into your unique metabolic profile, but it should not be used to diagnose health conditions or guide medical treatment. Because this variant influences how your body processes dietary fats, some people find this information useful when discussing nutritional strategies with a registered dietitian or a healthcare provider. However, there is no 'ideal' genotype, and genetic testing for this SNP is not a substitute for professional medical advice. If you are concerned about your lipid levels, inflammation, or dietary health, consult your physician or a qualified nutritionist. They can help you interpret your results in the context of your overall health, blood work, and lifestyle. Never make significant changes to your diet or supplement regimen based solely on genetic data without first consulting a clinician or pharmacist.
How common is this variant?
The frequency of the rs174550 alleles varies significantly across different global populations and ancestral backgrounds, making it a common but geographically diverse genetic marker.
Frequently asked questions
Does the rs174550 variant mean I have a health condition?
No, this variant is a normal genetic variation found in many people. It is associated with differences in how your body processes fats, not with the presence of a disease.
Should I change my diet based on my FADS1 genotype?
You should not make significant dietary changes based on this information alone. Consult with a registered dietitian or your doctor to discuss how your genetic profile might relate to your overall nutritional needs.
Can I use this SNP to predict my risk of heart disease?
While FADS1 variants are studied in the context of lipid metabolism, they are not diagnostic tools for heart disease. Heart health is determined by a complex combination of genetics, diet, exercise, and other environmental factors.
Where can I find more information about FADS1?
You can search for 'FADS1' on resources like MedlinePlus Genetics or the NCBI Gene database for authoritative, peer-reviewed information about the gene's function and related research.
Sources & further reading
Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs174550?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FADS1
Influences the efficiency of processing plant-based Omega-3 into EPA/DHA.
This variant in the FADS1 gene influences how efficiently the body converts plant-based fats into essential Omega-3 and Omega-6 fatty acids.
Key regulatory polymorphism governing the efficiency of dietary polyunsaturated fatty acid (PUFA) conversion to arachidonic and eicosapentaenoic acids.
Modulates long-chain polyunsaturated fatty acid biosynthesis efficiency and circulating arachidonic acid proportions.
This variant is located in the FADS gene cluster and is associated with variations in plasma levels of long-chain polyunsaturated fatty acids (LC-PUFAs).
Regulates fatty acid desaturase expression, altering conversion efficiency of dietary alpha-linolenic acid to EPA and DHA.